Nova Specialty Not EPS Dilutive: Apollo Health

Neeraj Garg, CEO at Apollo Health & Lifestyle, speaks to NDTV about the buyout of Nova Specialty for Rs 145 crore. He says the deal will be financed by a mix of both debt and equity, and will not be EPS dilutive.

Related Videos